Market Place
Sourcing Support
ExCellThera`s Blood Cancer Cell Therapy Zemcelpro Earns EU Nod
27 Aug 2025 //
PR NEWSWIRE
Zemcelpro Gets Positive CHMP Opinion for Blood Cancer Treatment
19 Jun 2025 //
PR NEWSWIRE
ExCellThera’s UM171 Cell Therapy Accepted for Accelerated Assessment by EMA
25 Jun 2024 //
GLOBENEWSWIRE
ExCellThera to Conduct Meetings During the J.P. Morgan 42nd Annual Conference
02 Jan 2024 //
GLOBENEWSWIRE
ExCellThera Announces Positive Phase 2 Study Results from UM171 Cell Therapy
12 Dec 2023 //
GLOBENEWSWIRE
ExCellThera announces new UM171 data to be presented at ASH 2023
03 Nov 2023 //
GLOBENEWSWIRE
UM171 cell therapy demonstrates improved outcomes compared to cord
12 Dec 2022 //
GLOBENEWSWIRE
ExCellThera announces completion of Phase 2 clinical trials for UM171
15 Nov 2022 //
GLOBENEWSWIRE
ExCellThera announces 100th patient treated with UM171-expanded cell therapy
08 Nov 2022 //
GLOBENEWSWIRE
ExCellThera announces oral presentation of new data UM171-expanded cell therapy
04 Nov 2022 //
GLOBENEWSWIRE
ExCellThera announces submission of Drug Master File for UM171
17 Jun 2022 //
GLOBENEWSWIRE
ExCellThera announces new publication showing its ECT-001 cell therapy
13 Apr 2022 //
GLOBENEWSWIRE
ExCellThera says new data to be presented at the EBMT 2022
15 Mar 2022 //
GLOBENEWSWIRE
ExCellThera says first patient treated in P I/II trial of ECT-001 cell therapy
10 Mar 2022 //
GLOBENEWSWIRE
ExCellThera: settlement of patent infringement claims against Selleck Chemicals
21 Dec 2021 //
GLOBENEWSWIRE
ExCellThera and Astellas enter into a license for the use of molecule UM171
13 Jul 2021 //
GLOBENEWSWIRE
Excellthera & Ossium Health Announce a Collab to Advance Their Technologies
21 Apr 2021 //
GLOBENEWSWIRE
ExCellThera announces UM171 mechanism of action
07 Jan 2021 //
GLOBENEWSWIRE
ExCellThera receives Priority Medicines (PRIME) designation from EMA
11 Dec 2020 //
GLOBENEWSWIRE
ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer
07 Nov 2019 //
FIERCE BIOTECH
ExCellThera enters into manufacturing & collaboration with New York Blood Center
07 May 2019 //
GLOBENEWSWIRE
La Jolla Pharma Gets Breakthrough Designation for Malaria Treatment
24 Apr 2019 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.